Non-invasive diagnostic techniques in pigmentary skin disorders and skin cancer.
diagnosis
diagnostic techniques
pigmentary skin disorders
skin cancer
Journal
Journal of cosmetic dermatology
ISSN: 1473-2165
Titre abrégé: J Cosmet Dermatol
Pays: England
ID NLM: 101130964
Informations de publication
Date de publication:
Feb 2022
Feb 2022
Historique:
revised:
04
10
2021
received:
23
08
2021
accepted:
11
10
2021
pubmed:
2
11
2021
medline:
5
2
2022
entrez:
1
11
2021
Statut:
ppublish
Résumé
Diagnosis of pigmentary skin disorders, pre-cancerous and cancerous skin diseases is traditionally relied on visual assessment. The most widely applied invasive diagnostic technique is the skin biopsy. There have been significant technological advances in non-invasive diagnostic methods for skin disorders. The objective of this article is to discuss different non-invasive diagnostic modalities, used in the diagnosis of pigmentary skin disorders and cutaneous cancers. Comprehensive literature search was performed to screen articles related to non-invasive diagnostic techniques in pigmentary skin disorders and cutaneous cancers. Articles published in journals indexed in PubMed were searched along with those in Google Scholar. Clinical trials, review articles, case series, case reports and other relevant articles were considered for review. References of relevant articles were also considered for review. Dermoscopy and ultrasonography were the only non-invasive diagnostic and imaging techniques available to dermatologists for many years. The advent of computed tomography (CT) and magnetic resonance imaging (MRI) augmented the visualization of deeper structures. Confocal laser microscopy (CLM) and reflectance spectrophotometers have showed promising results in the non-invasive detection of pigmented lesions. Optical coherence tomography (OCT), electrical impedance spectroscopy (EIS), multispectral imaging, high frequency ultrasonography (HFUS) and adhesive patch biopsy aid in the accurate diagnosis of benign, as well as neoplastic skin diseases. There have been significant advancements in non-invasive methods for diagnosis of dermatological diseases. These techniques can be repeatedly used in a comfort manner for the patient, and may offer an objective way to follow the course of a disease.
Sections du résumé
BACKGROUND
BACKGROUND
Diagnosis of pigmentary skin disorders, pre-cancerous and cancerous skin diseases is traditionally relied on visual assessment. The most widely applied invasive diagnostic technique is the skin biopsy. There have been significant technological advances in non-invasive diagnostic methods for skin disorders.
OBJECTIVE
OBJECTIVE
The objective of this article is to discuss different non-invasive diagnostic modalities, used in the diagnosis of pigmentary skin disorders and cutaneous cancers.
METHODS
METHODS
Comprehensive literature search was performed to screen articles related to non-invasive diagnostic techniques in pigmentary skin disorders and cutaneous cancers. Articles published in journals indexed in PubMed were searched along with those in Google Scholar. Clinical trials, review articles, case series, case reports and other relevant articles were considered for review. References of relevant articles were also considered for review.
RESULTS
RESULTS
Dermoscopy and ultrasonography were the only non-invasive diagnostic and imaging techniques available to dermatologists for many years. The advent of computed tomography (CT) and magnetic resonance imaging (MRI) augmented the visualization of deeper structures. Confocal laser microscopy (CLM) and reflectance spectrophotometers have showed promising results in the non-invasive detection of pigmented lesions. Optical coherence tomography (OCT), electrical impedance spectroscopy (EIS), multispectral imaging, high frequency ultrasonography (HFUS) and adhesive patch biopsy aid in the accurate diagnosis of benign, as well as neoplastic skin diseases.
CONCLUSION
CONCLUSIONS
There have been significant advancements in non-invasive methods for diagnosis of dermatological diseases. These techniques can be repeatedly used in a comfort manner for the patient, and may offer an objective way to follow the course of a disease.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
444-450Informations de copyright
© 2021 The Authors. Journal of Cosmetic Dermatology published by Wiley Periodicals LLC.
Références
Kittler H, Pehamberger H, Wolf K, Binder M. Diagnostic accuracy of dermoscopy. Lancet Oncol. 2002;3:159-165.
Blum A, Rassner G, Garbe C. The diagnosis of cutaneous melanocytic lesions. J Am Acad Dermatol. 2003;48:672-678.
Altamura D, Avramidis M, Menzies SW. Assessment of the optimal interval for and sensitivity of short-term sequential digital dermoscopy monitoring for the diagnosis of melanoma. Arch Dermatol. 2008;144:502-506.
Salerni G, Terán T, Puig S, et al. Meta-analysis of digital dermoscopy follow-up of melanocytic skin lesions: a study on behalf of the International Dermoscopy Society. J Eur Acad Dermatol Venereol. 2013;27:805-814.
Rajadhyaksha M, Grossman M, Esterowitz D, Webb RH, Anderson RR. In vivo confocal scanning laser microscopy of human skin: melanin provides strong contrast. J Invest Dermatol. 1995;104:946-952.
Borsari S, Pampena R, Lallas A, et al. Clinical indications for use of reflectance confocal microscopy for skin cancer diagnosis. JAMA Dermatol. 2016;152:1093-1098.
Gerger A, Koller S, Kern T, et al. Diagnostic applicability of in vivo confocal laser scanning microscopy in melanocytic skin tumors. J Invest Dermatol. 2005;124:493-498.
Langley RGB, Walsh N, Sutherland AE, et al. The diagnostic accuracy of in vivo confocal scanning laser microscopy compared to dermoscopy of benign and malignant melanocytic lesions: a prospective study. Dermatology. 2007;215:365-372.
Haroon A, Shafi S, Rao BK. Using reflectance confocal microscopy in skin cancer diagnosis. Dermatol Clin. 2017;35:457-464.
Lovatto L, Carrera C, Salerni G, Alós L, Malvehy J, Puig S. In vivo reflectance confocal microscopy of equivocal melanocytic lesions detected by digital dermoscopy follow-up. J Eur Acad Dermatol Venereol. 2015;29:1918-1925.
Carrera C, Marghoob AA. Discriminating nevi from melanomas. Dermatol Clin. 2016;34:395-409.
Alawi SA, Kuck M, Wahrlich C, et al. Optical coherence tomography for presurgical margin assessment of non-melanoma skin cancer-a practical approach. Exp Dermatol. 2013;22:547-551.
Mogensen M, Joergensen TM, Nürnberg BM, et al. Assessment of optical coherence tomography imaging in the diagnosis of non-melanoma skin cancer and benign lesions versus normal skin: observer-blinded evaluation by dermatologists and pathologists. Dermatol Surg. 2009;35:965-972.
Markowitz O, Schwartz M, Feldman E, et al. Evaluation of optical coherence tomography as a means of identifying earlier stage basal cell carcinomas while reducing the use of diagnostic biopsy. J Clin Aesthet Dermatol. 2015;8:14-20.
Tankam P, Soh J, Canavesi C, et al. Gabor-domain optical coherence tomography to aid in Mohs resection of basal cell carcinoma. J Am Acad Dermatol. 2019;80:1766-1769.
Gambichler T, Schmid-Wendtner MH, Plura I, et al. A multicentre pilot study investigating high-definition optical coherence tomography in the differentiation of cutaneous melanoma and melanocytic naevi. J Eur Acad Dermatol Venereol. 2015;29:537-541.
Wassef C, Rao BK. Uses of non-invasive imaging in the diagnosis of skin cancer: an overview of the currently available modalities. Int J Dermatol. 2013;52:1481-1489.
Welzel J, Schuh S. Noninvasive diagnosis in dermatology. J Dtsch Dermatol Ges. 2017;15:999-1016.
Braun RP, Mangana J, Goldinger S, French L, Dummer R, Marghoob AA. Electrical impedance spectroscopy in skin cancer diagnosis. Dermatol Clin. 2017;35:489-493.
Aberg P, Nicander I, Holmgren U, Geladi P, Ollmar S. Assessment of skin lesions and skin cancer using simple electrical impedance indices. Skin Res Technol. 2003;9:257-261.
Mavehy J, Hauschild A, Curiel-Lewandrowski C, et al. Clinical performance of the Nevisense system in cutaneous melanoma detection: an international, multicentre, prospective and blinded clinical trial on efficacy and safety. Br J Dermatol. 2014;171:1099-1107.
Ceder H, Hylen AS, Larko A-MW, Paoli J. Evaluation of electrical impedance spectroscopy as an adjunct to dermoscopy in short-term monitoring of atypical melanocytic lesions. Dermatol Pract Concept. 2016;6:1-6.
Kupetsky EA, Ferris LK. The diagnostic evaluation of MelaFind multi-spectral objective computer vision system. Expert Opin Med Diagn. 2013;7:405-411.
Carrara M, Tomati S, Bono A, et al. Automated segmentation of pigmented skin lesions in multispectral imaging. Phys Med Biol. 2005;50:N345-N357.
Farina B, Bartoli C, Bono A, et al. Multispectral imaging approach in the diagnosis of cutaneous melanoma: potentiality and limits. Phys Med Biol. 2000;45:1243-1254.
Tomatis S, Bono A, Bartoli C, et al. Automated melanoma detection: multispectral imaging and neural network approach for classification. Med Phys. 2003;30:212-221.
MacLellan AN, Price EL, Publicover-Brouwer P, et al. The use of non-invasive imaging techniques in the diagnosis of melanoma: a prospective diagnostic accuracy study. J Am Acad Dermatol. 2020:S0190-9622(20)30559-4.
Goeppert-Mayer M. uber Elementarakte mit zwei Quantensprungen. Ann Phys. 1931;9:229-231.
Koehler MJ, Lange-Asschenfeldt S, Kaatz M. Non-invasive imaging techniques in the diagnosis of skin diseases. Expert Opin Med Diagn. 2011;5:425-440.
Lentsch G, Balu M, Williams J, et al. In vivo multiphoton microscopy of melisma. Pigment Cell Melanoma Res. 2019;32:403-411.
Dimitrow E, Ziemer M, Koehler MJ, et al. Sensitivity and specificity of multiphoton laser tomography for in vivo and ex vivo diagnosis of malignant melanoma. J Invest Dermatol. 2009;129:1752-1758.
Tran KT, Wright NA, Cockerell CJ. Biopsy of the pigmented lesion-when and how. J Am Acad Dermatol. 2008;59:852-871.
Wachsman W, Morhenn V, Palmer T, et al. Noninvasive genomic detection of melanoma. Br J Dermatol. 2011;164:797-806.
Ferris LK, Jansen B, Ho J, et al. Utility of a noninvasive 2-gene molecular assay for cutaneous melanoma and effect on the decision to biopsy. JAMA Dermatol. 2017;153:675-680.
Gerami P, Alsobrook JP, Palmer TJ, Robin HS. Development of a novel noninvasive adhesive patch test for the evaluation of pigmented lesions of the skin. J Am Acad Dermatol. 2014;71:237-244.
Yao Z, Moy R, Allen T, Jansen B. An adhesive patch-based skin biopsy device for molecular diagnostics and skin microbiome studies. J Drugs Dermatol. 2017;16:979-986.
Crisan M, Crisan D, Sannino G, Lupsor M, Badea R, Amzica F. Ultrasonographic staging of cutaneous malignant tumors: an ultrasonographic depth index. Arch Dermatol Res. 2013;305:305-313.
Rallan D, Harland CC. Ultrasound in dermatology - basic principles and applications. Clin Exp Dermatol. 2003;28:632-638.
Lassau N, Spatz A, Avril MF, et al. Value of high-frequency US for preoperative assessment of skin tumors. Radiographics. 1997;17:1559-1565.
Bessoud B, Lassau N, Koscielny S, et al. High-frequency sonography and color Doppler in the management of pigmented skin lesions. Ultrasound Med Biol. 2003;29:875-879.
Pilat P, Borzecki A, Janienicki M, Gerkowicz A, Krasowska D. High-frequency ultrasound in the diagnosis of selected non-melanoma skin nodular lesions. Postepy Dermatol Alergol. 2019;36:572-580.
Bialvnicki-Birula R, Reszke R, Szepietowski JS. High-frequency ultrasonography (HFUS) as a useful tool in differentiating between plaque morphea and extragenital lichen sclerosus lesions. Postepy Dermatol Alergol. 2017;34:485-489.
Dreiseitl S, Ohno-Machado L, Kittler H, Vinterbo S, Billhardt H, Binder M. A comparison of machine learning methods for the diagnosis of pigmented skin lesions. J Biomed Inform. 2001;34:28-36.
Yang Y, Ge Y, Guo L, et al. Development and validation of two artificial intelligence models for diagnosing benign, pigmented facial skin lesions. Skin Res Technol. 2021;27:74-79.
Goyal M, Knackstedt T, Yan S, Hassanpour S. Artificial intelligence-based image classification methods for diagnosis of skin cancer: Challenges and opportunities. Comput Biol Med. 2020;127:104065.